Primary Care Enhanced Services
Overview
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board (ICB) is in the award stage of a procurement process concerning Primary Care Enhanced Services, governed by the Provider Selection Regime Regulations 2023. The intended contract participants include Millview Medical Centre. The service spans various components such as Phlebotomy, Treatment Rooms, and specialised drug monitoring, aimed at improving general-practitioner services within the UKF3 region, specifically Sleaford.
The direct award procurement, classified under the CPV 85121100 category, anticipates a contract period from 1st April 2025 to 31st March 2026 with a contract value of £112,440. The award notice marks the beginning of a standstill period, and representations must be submitted by 12th September 2025. This procurement presents significant opportunities for healthcare providers specialising in primary care services, particularly those focused on innovation and service sustainability.
Businesses with a track record of delivering quality healthcare, achieving health equity, and integrating services for enhanced patient choice stand to benefit. Small and medium enterprises (SMEs) like Millview Medical Centre may find it advantageous to demonstrate their capability in satisfying previously awarded contracts, as the procurement decision emphasizes satisfaction with existing contracts and social value contributions.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - DVT Assessment & Management including D-Dimer Testing
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - DVT Assessment & Management including D-Dimer Testing The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS112,440. The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- Tobacco Dependency Service in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- Provision of Intermediate Minor Oral Surgery and Conscious Sedation at Oasis - Lincoln in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- GP Practice Medical Cover for Hospice in the Hospital in North Kesteven